
Strategic Intent: Rubedo’s Seno-Adaptive Bet On Longevity Medicine
Sep 21, 2026 - 40:09
Radio and PodcastLive Radio & Podcasts
Everyone in consumer health is talking about GLP-1s. While this new generation of weight loss drugs is firmly on the prescription-only side, industry is now thinking about how it can meet users’ needs for products that a...